# US 2026/0041855 A1 · Electronic devices and liquids for aerosolizing and inhaling therewith

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0041855 A1
- Document ID: US20260041855A1
- Status: Published application
- Kind: A1
- Application number: 19/365,263
- Filed: 2025-10-22
- Published: 2026-02-12
- Earliest claimed: 2019-10-20
- Assignees: Qnovia, Inc.
- Applicants: Qnovia, Inc.
- Inventors: Mario Danek; Ian Kovacevich; Andrew Heinrich; Christopher Kar-Heng Cheng; Joseph Walsh
- Web page: https://patentgrep.com/patent/US20260041855A1

## CPC

- A61M 11/003: {by passing the aerosol trough sieves or filters}
- A24B 15/167: in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
- A24B 15/283: {by encapsulation of the chemical substances}
- A24F 40/05: Devices without heating means
- A24F 40/10: Devices using liquid inhalable precursors
- A24F 40/42: Cartridges or containers for inhalable precursors
- A24F 40/48: Fluid transfer means, e.g. pumps
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 31/465: Nicotine; Derivatives thereof
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 47/02: Inorganic compounds
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61M 11/001: {Particle size control}
- A61M 11/005: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/0085: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/06: Inhaling appliances shaped like cigars, cigarettes or pipes
- B05B 9/047: supply being effected by follower in container, e.g. membrane or floating piston {, or by deformation of container (B05B9/0838 takes precedence)}
- B05B 17/0653: {Details}
- B05B 17/0676: {Feeding means}
- A61M 2202/0468: non-physiological
- A61M 2205/0294: Piezoelectric materials
- A61M 2205/12: with interchangeable cassettes forming partially or totally the fluid circuit
- A61M 2205/583: by visual feedback
- A61M 2205/587: Lighting arrangements
- A61M 2205/8206: battery-operated
- B05B 17/0646: {Vibrating plates, i.e. plates being directly subjected to the vibrations, e.g. having a piezoelectric transducer attached thereto}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24F: SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES (inhaling appliances for medical purposes, shaped like cigars, cigarettes or pipes A61M15/06)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

An electronic device includes a mouthpiece, a bladder, and a mesh assembly having a mesh material and a piezoelectric material. The mesh material is in contact with a liquid of the bladder. The mouthpiece, the bladder, and the mesh assembly are located in-line along a longitudinal axis of the device between opposite longitudinal ends of the device, with the mesh assembly extending between and separating the mouthpiece and the bladder. A liquid-filled cartridge also is disclosed for use with an electronic device for delivery of a substance into a body through respiration includes a liquid container; and a liquid contained within the container for aerosolizing and inhaling by a person using the electronic device. The liquid includes a plurality of nanoparticles in a nanoemulsion, the nanoparticles including the encapsulation of the substance to be delivered into the body through respiration. The nanoemulsion preferably is produced using a microfluidizing machine.

## Claims

### Claim 1

An electronic device for producing an aerosol for inhalation by a person, comprising:
(a) a mouthpiece;
(b) a bladder containing a liquid;
(c) a mesh assembly comprising a mesh material and a piezoelectric material, wherein the mesh material is configured to vibrate when the piezoelectric material is actuated whereby the aerosol is produced when the mesh material contacts the liquid of the liquid container such that the aerosol may be inhaled through the mouthpiece; and
(d) circuitry and a power supply for actuating the mesh assembly.

### Claim 2 (depends on 1)

The electronic device of claim 1, wherein the bladder and mesh assembly are located in a removable cartridge of the electronic device.

### Claim 3 (depends on 2)

The electronic device of claim 2, wherein the cartridge mounts onto an end of base housing of the electronic device, which base housing contains the circuitry and the power supply for actuating the mesh assembly.

### Claim 4 (depends on 2)

The electronic device of claim 2, wherein the cartridge forms the mouthpiece of the electronic device.

### Claim 5 (depends on 2)

The electronic device of claim 2, wherein electrical contacts of the mesh assembly interface with electrical contacts connecting to the circuitry and power supply when the cartridge is mounted onto the end of the base housing of the electronic device.

### Claim 6 (depends on 1)

The electronic device of claim 1, wherein the bladder contains between about 1 ml and 3 ml of the liquid.

### Claim 7 (depends on 1)

The electronic device of claim 1, wherein the mesh assembly comprises a piezo mesh disk.

### Claim 8 (depends on 3)

The electronic device of claim 3, wherein the mesh assembly comprises an annular ring and wherein the mesh material is located within the area bounded by the annual ring.

### Claim 9 (depends on 1)

The electronic device of claim 1, wherein the mesh material is flat.

### Claim 10 (depends on 1)

The electronic device of claim 1, wherein the mesh material is dome-shaped.

### Claim 11 (depends on 1)

The electronic device of claim 1, wherein the mesh material is constructed from a metal alloy.

### Claim 12 (depends on 1)

The electronic device of claim 1, wherein the mesh material is produced by electroplating.

### Claim 13 (depends on 1)

The electronic device of claim 1, wherein the mesh material is produced by laser cutting.

### Claim 14 (depends on 1)

The electronic device of claim 1, wherein the mesh material is in the form of a mesh plate.

### Claim 15 (depends on 1)

The electronic device of claim 1, further comprising a sensor that detects when a person inhales, and wherein the mesh assembly is actuated in response to the detection of inhalation by a person.

### Claim 16 (depends on 1)

The electronic device of claim 1, wherein the cartridge is a single-use, disposable cartridge.

### Claim 17 (depends on 1)

The electronic device of claim 1, wherein the cartridge further comprises a port through which the aerosolized liquid is inhaled.

### Claim 18 (depends on 17)

The electronic device of claim 17, wherein the cartridge serves as a mouthpiece of the electronic device.

### Claim 19

A liquid-filled cartridge for use with an electronic device for delivery of a substance into a body through respiration, comprising:
(a) a liquid container; and
(b) a liquid for aerosolizing and inhaling by a person using the electronic device, the liquid being contained within the liquid container and comprising a nanoemulsion, each of a plurality of nanoparticles of the nanoemulsion comprising an encapsulation of the substance to be delivered into the body through respiration.

### Claim 20 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the liquid is an oil-in-water nanoemulsion.

### Claim 21 (depends on 19)

The liquid-filled cartridge of claim 19, wherein each nanoparticle is a micelle.

### Claim 22 (depends on 19)

The liquid-filled cartridge of claim 19, wherein each nanoparticle is a liposome.

### Claim 23 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the substance is encapsulated by a polymer.

### Claim 24 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the substance is encapsulated by a surfactant.

### Claim 25 (depends on 24)

The liquid-filled cartridge of claim 24, wherein the surfactant comprises high purity polyoxyethylene sorbitan monooleate.

### Claim 26 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the encapsulated substance comprises tetrahydrocannabinol.

### Claim 27 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the encapsulated substance comprises cannabidiol.

### Claim 28 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the encapsulated substance comprises tetrahydrocannabinol and cannabidiol.

### Claim 29 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the encapsulated substance comprises a pharmaceutical compound.

### Claim 30 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the encapsulated substance comprises nicotine.

### Claim 31 (depends on 19)

The liquid-filled cartridge of claim 19, wherein the nanoparticles are dispersed within an aqueous solution.

### Claim 32 (depends on 31)

The liquid-filled cartridge of claim 31, wherein the aqueous solution comprises a saline.

### Claim 33 (depends on 32)

The liquid-filled cartridge of claim 32, wherein the aqueous solution comprises sodium chloride.

### Claim 34 (depends on 33)

The liquid-filled cartridge of claim 33, wherein the nanoparticles are dispersed within an aqueous solution of 0.9% sodium chloride.

### Claim 35 (depends on 19)

The liquid-filled cartridge of claim 19, wherein a pH of the liquid is between about 5.5 and about 8.

### Claim 36 (depends on 19)

The liquid-filled cartridge of claim 19, wherein a pH of the liquid is between about 6.5.

### Claim 37 (depends on 19)

The liquid-filled cartridge of claim 19, wherein a molecular ratio of the encapsulated substance to an encapsulating agent of the nanoparticle is between about 0.1:1 to about 10:1.

### Claim 38 (depends on 19)

The liquid-filled cartridge of claim 19, wherein a polydispersity index measurement of the nanoemulsion is less than 0.3.

### Claim 39

A method of manufacturing cartridges for use with an electronic device for delivery of a substance into a body through respiration, comprising filling a liquid container of the cartridge with a liquid for aerosolizing and inhaling by a person using the electronic device, the liquid comprising a plurality of nanoparticles in a nanoemulsion, each nanoparticle comprising an encapsulation of the substance to be delivered into the body through respiration.

### Claim 40 (depends on 39)

The method of claim 39, further comprising a preliminary step of producing the nanoemulsion by processing the substance to be delivered together with the encapsulating agent using a microfluidizing machine.

### Claim 41 (depends on 40)

The method of claim 40, further comprising operating the microfluidizing machine such that a temperature of the processing does not exceed 65° C., while producing the nanoemulsion.

### Claim 42 (depends on 40)

The method of claim 40, further comprising the step of adjusting pH of the nanoemulsion so as to be between about 5.5 and 8.

### Claim 43 (depends on 40)

The method of claim 40, further comprising the step of chemically bonding the substance to be encapsulated with another molecule prior to processing the substance with the encapsulating agent using the microfluidizing machine.

### Claim 44 (depends on 40)

The method of claim 40, wherein a polydispersity index measurement of the nanoemulsion after processing using the microfluidizing machine is less than 0.3.

### Claim 45

A method of manufacturing a liquid for aerosolizing and inhaling by a person using an electronic device for the delivery of a substance to the body of the person through respiration, the method comprising producing a liquid mixture comprising a plurality of nanoparticles in a nanoemulsion by processing the substance together with an encapsulating agent using a microfluidizing machine such that the plurality of nanoparticles of the nanoemulsion comprises the encapsulated substance.

### Claim 46 (depends on 45)

The method of claim 45, further comprising operating the microfluidizing machine such that a temperature of the processing does not exceed 65° C., while producing the nanoemulsion.

### Claim 47 (depends on 45)

The method of claim 45, further comprising the step of adjusting pH of the nanoemulsion so as to be between about 5.5 and 8.

### Claim 48 (depends on 45)

The method of claim 45, further comprising the step of chemically bonding the substance to be encapsulated with another molecule prior to processing the substance with the encapsulating agent using the microfluidizing machine.

### Claim 49 (depends on 45)

The method of claim 45, wherein a polydispersity index measurement of the nanoemulsion after processing using the microfluidizing machine is less than 0.3.
